LEGISLATIVE BUDGET BOARD Austin, Texas FISCAL NOTE, 81ST LEGISLATIVE REGULAR SESSION May 1, 2009 TO: Honorable Lois W. Kolkhorst, Chair, House Committee on Public Health FROM: John S. O'Brien, Director, Legislative Budget Board IN RE:HB2163 by Turner, Sylvester (Relating to a study regarding the provision of certain medications through the Medicaid vendor drug program to children younger than 16 years of age.), Committee Report 1st House, Substituted No significant fiscal implication to the State is anticipated. The bill would add Section 531.0731 to the Government Code, to require the Health and Human Services Commission to conduct a study on certain medications being provided through the Medicaid vendor drug program to children younger than 16 years of age. The agency would report the results of the study by November 10, 2010. The bill would take effect September 1, 2009. The Health and Human Services Commission indicates that the costs of the study could be absorbed within existing resources at the agency. Local Government Impact No fiscal implication to units of local government is anticipated. Source Agencies:529 Health and Human Services Commission LBB Staff: JOB, CL, MB
LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 81ST LEGISLATIVE REGULAR SESSION
May 1, 2009
TO: Honorable Lois W. Kolkhorst, Chair, House Committee on Public Health FROM: John S. O'Brien, Director, Legislative Budget Board IN RE:HB2163 by Turner, Sylvester (Relating to a study regarding the provision of certain medications through the Medicaid vendor drug program to children younger than 16 years of age.), Committee Report 1st House, Substituted
TO: Honorable Lois W. Kolkhorst, Chair, House Committee on Public Health
FROM: John S. O'Brien, Director, Legislative Budget Board
IN RE: HB2163 by Turner, Sylvester (Relating to a study regarding the provision of certain medications through the Medicaid vendor drug program to children younger than 16 years of age.), Committee Report 1st House, Substituted
Honorable Lois W. Kolkhorst, Chair, House Committee on Public Health
Honorable Lois W. Kolkhorst, Chair, House Committee on Public Health
John S. O'Brien, Director, Legislative Budget Board
John S. O'Brien, Director, Legislative Budget Board
HB2163 by Turner, Sylvester (Relating to a study regarding the provision of certain medications through the Medicaid vendor drug program to children younger than 16 years of age.), Committee Report 1st House, Substituted
HB2163 by Turner, Sylvester (Relating to a study regarding the provision of certain medications through the Medicaid vendor drug program to children younger than 16 years of age.), Committee Report 1st House, Substituted
No significant fiscal implication to the State is anticipated.
No significant fiscal implication to the State is anticipated.
The bill would add Section 531.0731 to the Government Code, to require the Health and Human Services Commission to conduct a study on certain medications being provided through the Medicaid vendor drug program to children younger than 16 years of age. The agency would report the results of the study by November 10, 2010. The bill would take effect September 1, 2009. The Health and Human Services Commission indicates that the costs of the study could be absorbed within existing resources at the agency.
The bill would add Section 531.0731 to the Government Code, to require the Health and Human Services Commission to conduct a study on certain medications being provided through the Medicaid vendor drug program to children younger than 16 years of age. The agency would report the results of the study by November 10, 2010.
The bill would take effect September 1, 2009.
The Health and Human Services Commission indicates that the costs of the study could be absorbed within existing resources at the agency.
Local Government Impact
No fiscal implication to units of local government is anticipated.
Source Agencies: 529 Health and Human Services Commission
529 Health and Human Services Commission
LBB Staff: JOB, CL, MB
JOB, CL, MB